Nonradiological Treatment for Lung Tumors
Lung cancer is a major public health problem. In the USA, approximately 220,000 patients are diagnosed annually and 160,000 die, far more than from prostate or breast cancer (American Cancer Society 2010 Cancer Statistics). Worldwide, lung cancer is the leading cause of cancer mortality, and the World Health Organization estimates 1.3 million deaths per year. The 5-year survival rate is only approximately 15%, and this survival has not changed dramatically over the past three decades.
KeywordsNational Comprehensive Cancer Network National Comprehensive Cancer Network Intensity Modulate Radiation Therapy Stereotactic Body Radiation Therapy Radiation Therapy Oncology Group
- 1.Dempke WC, Suto T, Reck M. Targeted therapies for non-small cell lung cancer. Lung Cancer. 2010;67(3):257–74. Epub 2009 Nov 14.Google Scholar
- 2.AJCC Cancer Staging Handbook. American Joint Committee On Cancer. 7th ed. New York: Springer; 2010.Google Scholar
- 4.Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest. 2007;132(3 Suppl):243 S–65 S.Google Scholar
- 5.National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, non-small cell lung cancer, v2.2010. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf. Accessed 1 Dec 2010.
- 6.Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, et al., Cancer Care Ontario, American Society of Clinical Oncology. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol. 2007;25(34):5506–18. Epub 2007 Oct 22.Google Scholar
- 10.National Institute for Clinical Excellence. The diagnosis and treatment of lung cancer: methods, evidence, and guidance. http://www.nice.org.uk/nicemedia/pdf/cg024fullguideline.pdf. Accessed 1 Dec 2010.
- 18.Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005;128(1):237–45.PubMedCrossRefGoogle Scholar
- 20.British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax. 2001;56(2):89–108.Google Scholar
- 21.Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT, American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd ed.). Chest. 2007;132(3 Suppl):161 S–77 S.Google Scholar
- 27.Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61(2):318–28.PubMedCrossRefGoogle Scholar
- 32.Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys. 2007;68(3):786–93. Epub 2007 Mar 26.PubMedCrossRefGoogle Scholar
- 37.Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2(7 Suppl 3):S94–100.PubMedCrossRefGoogle Scholar
- 40.D’Cunha J, Herndon JE 2nd, Herzan DL, Patterson GA, Kohman LJ, Harpole DH et al., Cancer and Leukemia Group B. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer. 2005;48(2):241–6. Epub 2005 Jan 4.Google Scholar